Search
for
Sort by
Research 691–720 of 1000+
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- Metastatic Embryonal Cell Carcinoma with High Testosterone and Absence of Secondary Sexual Characteristics
- Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior
- Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate
- Women’s Health Care During the Perimenopause
- Introductory Chapter: Alopecia Management – An Update
- Nonsurgical Therapy for Hair Loss
- Introduction to: Endocrinological aspects of andrology—what is new?
- FINASTERIDA E CALVÍCIE ANDROGENÉTICA: em busca de uma terapêutica embasada na atenção integral à saúde do homem
- Finasteride
- Management of androgenetic alopecia: a review
- Finasteride
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- COMPLICAÇÕES DOS TRATAMENTOS DA ALOPÉCIA ANDROGÉNICA: REVISÃO SISTEMÁTICA E META-ANÁLISE
- Fetal gender: preferences, predictions, and its impact on women's sexuality, physical activity, and well-being during pregnancy
- PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Notes from the Editor Emeritus: Coincidental Epigenetics or Post-Finasteride Syndrome (PFS)?
- Finasteride
- Oral Minoxidil Therapy in Hair Loss: Where Do We Stand?
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- (282) CONSEQUENCES OF ANABOLIC-ANDROGENIC STEROID ABUSE IN MALES: RESULTS FROM A META-ANALYSIS STUDY
- Post-finasteride syndrome
- Testosterone: The Male Sex Hormone
- EndoPump Male Enhancement [Get 100% Genuine Result] Achieve Bigger | Harder Erections With This Supplement(Work Or Hoax)
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Testosterone metabolite nonessential for androgen effects
- PLASMA UNBOUND AND UNCONJUGATED ANDROGENS IN ORIENTAL MEN
- Overactive bladder in men